Human Longevity is a San Francisco-based biotechnology and healthtech company that acts as a strategic capital provider for U.S. health-related startups. It has early-stage VC investment activity, with relevance for biotechnology, HealthTech, life sciences, medical devices, and AI-enabled health companies. The company’s operating focus spans genomics-led precision prevention, longevity diagnostics, whole genome sequencing, whole-body MRI, biomarker testing, and clinician-guided care.